Pfizer discontinues daily weight-loss drug over liver toxicity concerns
.thumb.png.ea12d62fcb43a79b1d7a7a4664107cbc.png)
Entry posted by ADMIN
65 views
Pfizer expects to finalise plans for danuglipron late-stage program by end of year, developing once-daily, modified-release version of drug
0
0 Comments
Recommended Comments
There are no comments to display.
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.